NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Distribution · USD

Henry Schein, Inc. (HSIC) Stock Analysis

Henry Schein, Inc. (HSIC) is a Medical Distribution stock listed on NASDAQ and quoted in US Dollar.

HSIC

$89.81

−$1.05 (−1.16%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HSIC with… →

HSIC Key Statistics

As of Sep 4, 2026
Trading
Open
$89.91
Previous Close
$90.86
Day's Range
89.65–90.54
52-Week Range
61.95–92.18
Volume
887.90K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.81
Valuation
Market Cap
$10.01B
P/E Ratio
26.49
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
14.97
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.81
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.74
EPS (ttm)Profit attributable to each share over the last twelve months.
3.39
Financials (FY)
Revenue (FY)
$13.18B+4.03%
Net Income (FY)
$398.00M+2.05%
Profit marginThe share of revenue left as profit after all costs and taxes.
2.96%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
111.45M
1-Year Return
+32.50%
Dividend and dates
Earnings Date
November 3, 2026
Avg Volume
1.26M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HSIC Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+18.83%
2025+9.22%
2024−8.60%
2023−5.21%
2022+3.02%
2021+15.96%
2020+0.21%
2019+8.34%
2018+12.36%
2017−7.88%
2016 (partial year)−8.62%

As of September 4, 2026.

HSIC Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$13.18B$398.00M3.0%
2024$12.67B$390.00M3.1%
2023$12.34B$416.00M3.4%
2022$12.65B$538.00M4.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$13.18B$4.11B$758.00M$398.00M3.0%
2024$12.67B$4.02B$731.00M$390.00M3.1%
2023$12.34B$3.86B$695.00M$416.00M3.4%
2022$12.65B$3.83B$878.00M$538.00M4.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

HSIC Valuation vs Medical Distribution Median

Median of 13 stocks
MetricHSICMedical Distribution medianvs median
P/E26.4925.783% above
P/S ratio0.740.36104% above
Profit margin2.96%−4.03%7.0 pts above

Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Henry Schein, Inc. (HSIC) at $10.01B. It is classified in the Medical Distribution industry, within the Healthcare sector. The company reports 25,000 employees.

Over the past 52 weeks the price has ranged from $61.95 to $92.18. HSIC last closed at $89.81 on September 4, 2026. That is −$1.05 (−1.16%) against the previous close. The latest close sits 44.97% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $13.18B. Against the prior fiscal year total of $12.67B, that is a change of +4.03%. The same year closed with net income of $398.00M. That is +2.05% against the prior fiscal year. The reported profit margin is 2.96%. That is 7 percentage points above the Medical Distribution median of −4.03%. Earnings per share on a trailing basis come to 3.39.

Across the 4 fiscal years on file, revenue moves from $12.65B in 2022 to $13.18B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

HSIC trades at a trailing price-to-earnings ratio of 26.49. That is 2.75% above the Medical Distribution median of 25.78. The forward P/E on file is 14.97. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.81. Measured against sales, the shares trade at 0.74 times revenue. On price-to-sales that is 103.7% above the Medical Distribution median of 0.36. 13 Medical Distribution companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.81. Daily returns over the trailing 10 years annualize to a volatility of 27.47%. The trailing one-year price return is +32.50%. Across 10 years the annualized return works out at +3.38%.

Growth & Income

The record shows no dividend for HSIC.

So far in 2026 the price is +18.83%. Across the complete calendar years on file, 2021 returned +15.96% and 2024 returned −8.60%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

Henry Schein, Inc. (HSIC) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Henry Schein, Inc. HSIC $10.01B 26.5
McKesson Corporation MCK $105.86B 24.7
Cencora, Inc. COR $63.15B 25.1
Cardinal Health, Inc. CAH $57.49B 34.4

The Medical Distribution industry average P/E ratio is 25.8x. Henry Schein, Inc. trades at a P/E of 26.5.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Distribution Stocks

MCK

McKesson Corporation

$105.86B

 COR

Cencora, Inc.

$63.15B

 CAH

Cardinal Health, Inc.

$57.49B

 AHG

Akso Health Group

$726.49M

 FOCL

EDAP TMS S.A.

$190.70M

 QIPT

Quipt Home Medical Corp

$162.30M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Visit website →